Science Explorer Interactive view Map
Hospital / health system · Dallas · ??

Harold C. Simmons Comprehensive Cancer Center

World rank, all time
#15,696
of 42,892
Rank in ??
#207
of 1,041
Research works
221
▲ 87% vs 2013–17
Citations
11k
47.9 per fractional work
Top-10% rate
25.6%
record average 16.5%
Open access
44%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.67× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 2.35× its world share, 1 worksImmunology and Micro…Chemistry: 0.34× its world share, 0 worksChemistryComputer Science: 0.03× its world share, 0 worksComputer ScienceEngineering: 0.02× its world share, 0 worksEngineeringEnvironmental Science: 0.05× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.05× its world share, 0 worksMaterials ScienceMathematics: 0.40× its world share, 0 worksMathematicsPhysics and Astronomy: 0.22× its world share, 0 worksPhysics and AstronomyDentistry: 0.83× its world share, 0 worksDentistryHealth Professions: 1.08× its world share, 1 worksHealth ProfessionsMedicine: 3.41× its world share, 27 worksMedicineNursing: 0.24× its world share, 0 worksNursingDecision Sciences: 0.14× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 2.03× its world share, 2 worksEconomics, Econometr…Psychology: 0.03× its world share, 0 worksPsychologySocial Sciences: 0.17× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.7×. Every wedge is a field page.

Who are the top researchers at Harold C. Simmons Comprehensive Cancer Center?

Ranked on the composite score, James K. V. Willson lead among researchers whose main affiliation is Harold C. Simmons Comprehensive Cancer Center.

  1. 1 James K. V. Willson ?? · #28,828 worldwide 654 citations · 39 works
All ranked researchers at Harold C. Simmons Comprehensive Cancer Center

Which keywords describe research at Harold C. Simmons Comprehensive Cancer Center?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Prognostic Factors, Cancer, Targeted Therapy, Lymphoma, Breast Cancer and Clinical Trials.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy5▲ 17×16 topics
  2. Chemotherapy4▲ 15×21 topics
  3. Prognostic Factors4▲ 21×12 topics
  4. Cancer4▲ 6.3×22 topics
  5. Targeted Therapy3▲ 34×4 topics
  6. Lymphoma3▲ 41×3 topics
  7. Breast Cancer2▲ 26×7 topics
  8. Clinical Trials2▲ 9.0×7 topics
  9. Tumor Microenvironment2▲ 14×7 topics
  10. Molecular Characterization2▲ 26×4 topics
  11. Rituximab2▲ 28×2 topics
  12. Genetic Mutations2▲ 9.6×9 topics
  13. PET Imaging2▲ 24×4 topics
  14. Therapy2▲ 20×4 topics
  15. Cancer Genomics2▲ 53×1 topic
  16. Clinical Practice Guidelines2▲ 6.9×8 topics
  17. Molecular Profiling2▲ 38×3 topics
  18. Mutational Signatures2▲ 53×1 topic
  19. Tumor Regression2▲ 37×2 topics
  20. Cancer Immunotherapy2▲ 23×3 topics
  21. Clinical Guidelines2▲ 12×5 topics
  22. Gene Expression Profiling2▲ 44×2 topics
  23. Leukemia2▲ 43×2 topics
  24. Metastasis2▲ 10×9 topics
  25. Cancer Incidence1▲ 25×4 topics
  26. Metastatic1▲ 55×2 topics
  27. Biomarkers1▲ 4.6×5 topics
  28. CAR T Cells1▲ 43×1 topic
  29. Chimeric Antigen Receptor1▲ 43×1 topic
  30. Immune Checkpoint Blockade1▲ 28×1 topic
  31. Metastatic Breast Cancer1▲ 55×2 topics
  32. Neoadjuvant Therapy1▲ 13×5 topics
  33. PD-1 and PD-L11▲ 28×1 topic
  34. Classification1▲ 6.5×1 topic
  35. Genetic Pathogenesis1▲ 55×1 topic
  36. Radiotherapy1▲ 7.4×8 topics
  37. Signaling1▲ 50×3 topics
  38. CDK4/6 Inhibitors1▲ 111×1 topic
  39. Palbociclib1▲ 111×1 topic
  40. Nephron-Sparing Surgery1▲ 73×1 topic

Which research topics does Harold C. Simmons Comprehensive Cancer Center publish most on?

By volume in 2022–2025: Cancer Genomics and Diagnostics, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers and Lymphoma Diagnosis and Treatment.

  1. 1 Cancer Genomics and Diagnostics Cancer Research 2 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 1 works
  4. 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  5. 5 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  6. 6 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 1 works
  7. 7 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  8. 8 Renal and related cancers Molecular Biology 1 works
  9. 9 Lung Cancer Research Studies Oncology 1 works
  10. 10 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.6%not open56.4%

World: 28% of research is openly available.

with international co-authors11.9%domestic only88.1%

World: 19% is written across borders.

How has Harold C. Simmons Comprehensive Cancer Center's research output changed?

Output in 2018–2022 was 87% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Dallas

All research institutions in Dallas

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.